Dr. Meyer is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
875 Oak St SE
Ste 4030
Salem, OR 97301Phone+1 503-561-6444
Education & Training
- Oregon Health & Science University (OHSU Health)Fellowship, Hematology and Medical Oncology, 2009 - 2012
- University of Arizona College of Medicine-TucsonResidency, Internal Medicine, 2005 - 2009
- University of Utah School of MedicineClass of 2005
Certifications & Licensure
- CA State Medical License 2014 - Present
- OR State Medical License 2009 - 2025
- IL State Medical License 2012 - 2017
- AZ State Medical License 2008 - 2009
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
Clinical Trials
- S1201: Combination Chemo for Patients W/Advanced or Metastatic Esophageal, Gastric, or Gastroesophageal Junction Cancer Start of enrollment: 2012 Feb 01
- Pazopanib Hydrochloride in Treating Patients With Progressive Carcinoid Tumors Start of enrollment: 2013 Sep 20
- Sorafenib Tosylate in Treating Patients With Desmoid Tumors or Aggressive Fibromatosis Start of enrollment: 2014 Mar 21
Publications & Presentations
PubMed
- 26 citationsEvaluation of Soft Tissue Sarcoma Response to Preoperative Chemoradiotherapy Using Dynamic Contrast-Enhanced Magnetic Resonance Imaging.Wei Huang, Brooke Beckett, Alina Tudorica, Janelle M. Meyer, Aneela Afzal
Tomography. 2016-12-01 - 63 citationsPhase I trial of preoperative chemoradiation plus sorafenib for high-risk extremity soft tissue sarcomas with dynamic contrast-enhanced MRI correlates.Janelle M. Meyer, Kelly Shea Perlewitz, James B. Hayden, Yee Cheen Doung, Arthur Y. Hung
Clinical Cancer Research. 2013-12-15
Press Mentions
- Oregon Oncology Specialists Integrate AI-Screening Solution VIPER™ into Network to Expand Patient Access to Clinical TrialsApril 16th, 2021
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: